Olesoxime in neurodegenerative diseases: Scrutinising a promising drug candidate
Jonasz Jeremiasz Weber(University Hospitals of the Ruhr-University of Bochum), Huu Phuc Nguyen(University of Tübingen), Laura E. Clemensson(Uppsala University), Helgi B. Schiöth(Uppsala University)
Cited by 30
Related Papers
Recent developments of HDAC inhibitors: Emerging indications and novel molecules
|British Journal of Clinical Pharmacology|2021|407
Calpain-mediated ataxin-3 cleavage in the molecular pathogenesis of spinocerebellar ataxia type 3 (SCA3)
|Human Molecular Genetics|2012|78
From Pathways to Targets: Understanding the Mechanisms behind Polyglutamine Disease
|BioMed Research International|2014|70
A shift in the collagen V antigenic epitope leads to T helper phenotype switch and immune response to self-antigen leading to chronic lung allograft rejection
|Clinical & Experimental Immunology|2011|56
Decreased iron absorption in patients with active rheumatoid arthritis, with and without iron deficiency.
|Annals of the Rheumatic Diseases|1988|56